The HMGN1 Knockout HAP1 Polyclonal Cells product provides a heterogeneous population of HAP1 cells with CRISPR/Cas9-mediated disruption of the HMGN1 locus, offering a cost-effective model for loss-of-function studies without clonal isolation. This polyclonal knockout pool captures a diverse array of edits, ensuring robust representation for population-scale functional genomics and chromatin biology research. Designed for investigators probing chromatin dynamics and transcription regulation, the cells facilitate high-throughput and mechanistic assays.
HAP1 cells are a near-haploid human cell line originating from the KBM-7 chronic myeloid leukemia lineage. Their haploid genome simplifies genetic analysis, enabling direct genotype-phenotype correlations in knockout experiments. The absence of a second gene copy avoids compensation effects, ensuring that loss-of-function phenotypes are unequivocally linked to the targeted gene disruption. Widely employed in functional genomics and genetic screens, HAP1 cells maintain active chromatin remodeling and transcriptional machinery, making them a relevant host for studying modulators like HMGN1 in a defined cellular context.
HMGN1 encodes a nucleosome-binding protein that destabilizes chromatin to facilitate transcriptional activation and DNA repair. This chromatin remodeling function is critical for allowing access of transcription factors and repair proteins to DNA. It directly interacts with nucleosomes and histone H2A, and cooperates with transcription factors such as SP1 and NF-??B to promote gene expression. HMGN1 operates downstream of cellular stress and growth factor signaling pathways, influencing the expression of cell cycle regulators (CCND1, c-MYC) and differentiation markers. By modulating chromatin accessibility, HMGN1 plays a critical role in rapid gene induction and efficient DNA damage responses. In the knockout cells, disruption of HMGN1 leads to condensed chromatin and altered transcriptional programs, providing a tractable system to dissect these molecular mechanisms.
In the haploid HAP1 background, HMGN1 knockout offers a simplified model to study chromatin dynamics without the buffering effects of a second allele. This system is particularly suited for high-resolution chromatin assays, including ChIP-seq for histone modification mapping and immunofluorescence for nuclear organization. Transcriptomic profiling via RNA-seq can reveal genome-wide expression changes, while DNA damage response assays and cell proliferation studies explore the consequences on genomic stability and cell cycle control. The polyclonal nature ensures that observed phenotypes represent population-level responses, enhancing statistical rigor. Combined with protein validation by western blotting, researchers can comprehensively assess HMGN1 function. These studies clarify HMGN1’s roles in chromatin maintenance and gene regulation.
These knockout cells are broadly applicable in functional genomics, cancer biology, and developmental disorder research. Typical assays include western blotting to confirm HMGN1 protein depletion, RT-qPCR for quantifying target gene expression, and chromatin accessibility assays to evaluate nucleosome positioning. The model supports investigations into upstream regulators such as cellular stress signals and downstream proliferation markers CCND1 and c-MYC, as well as interactions with chromatin remodeling complexes. For detailed product information or technical support, please contact Ascent Research.
